Oppenheimer Reiterates Outperform Rating on KLA

Analyst: Ed Yang 1 min read Reproduced verbatim
Rating
Outperform
Unchanged
Target
$1,800
Unchanged
Outcome
Reached
on April 20, 2026

Oppenheimer’s latest target on KLA is now $260 (Jul 16, 2026); the median of 11 firms is $220. Oppenheimer has reached 76% of its year-old targets (29 scored).

Oppenheimer and KLA logos

What the analyst said

Oppenheimer analyst Ed Yang reiterated an Outperform rating and $1,800.00 price target on KLA Corporation (NASDAQ: KLAC).

“We expect KLA’s Investor Day (3/12) to recenter investors on longterm basics, away from recent external disruptions toward why it remains the premier growth franchise in semicap, outgrowing WFE with the highest margins and minimal China competition.

Management will likely deep-dive into how AI’s substantially increasing inspection and measurement intensity due to design diversity, larger, higher value chips and tougher manufacturing steps. We think KLA could moderately raise its five-year revenue and EPS CAGR targets by ~100–200 bps, similar in magnitude to the 2022 CMD.

This might be conservative, but leaves appropriate room for cyclicality over a multi-year period, while reinforcing the company’s consistent ability to outgrow WFE. We raise FY27E by 2%, and reiterate Outperform with a $1800 PT (39x P/E)… We view the recent pullback in KLA shares as an opportunity, resolving our main near-term concern after January’s extreme overbought conditions (+40% vs. S&P +2%).

Valuation has since moderated from ~42x to ~32x. We believe KLA remains a must-own franchise, one of the highestquality structural AI beneficiaries within a semicap supercycle with significant longterm upside.”

Cite this note: Price Target, "Oppenheimer Reiterates Outperform Rating on KLA," March 11, 2026. https://price-target.com/2026/03/11/170660/
Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

KLAC trades at $127. The 11 analysts who set a target in the last 3 months range from $180 to $275, with a median of $220. This split-adjusted $180 target is 18% below the median, the lowest on the Street.

Since the note KLAC has moved −13% (from $145). 12-month window: day 254 of 365, closes on March 11, 2027.

Track record

This call✓ Target reached on April 20, 2026, 3 months after the note. Prices are split-adjusted. Same target as this firm’s January 30, 2026 note, so it is scored there.

Firm track recordOppenheimer: 76% of its 29 targets at least a year old were reached within 12 months (#18 of 29 firms); on KLA, 3 of 3. Accuracy ranking →

Oppenheimer on KLA

Oppenheimer price targets on KLA

8 calls from April 11, 2025 to July 16, 2026. The target went from $700 to $2,600 (+271%). The rating stayed Buy.

Oppenheimer targetKLAC share price
  1. July 16, 2026Target raised from $2,000 (+30%)Buy$2,600
  2. April 30, 2026Target raised from $1,800 (+11%)Buy$2,000
  3. March 11, 2026 This noteKept the $1,800 targetBuy$1,800
  4. January 30, 2026Target raised from $1 (+179900%)Buy$1,800
  5. August 1, 2025Target cut from $950 (−100%)Buy$1
  6. June 17, 2025Target raised from $740 (+28%)Buy$950
  7. May 1, 2025Target raised from $700 (+6%)Buy$740
  8. April 11, 2025Earliest call shownBuy$700

Targets are adjusted for the 10-for-1 split on Jun 12, 2026, so every call is in the same share terms as this note.

Share Reddit StockTwits
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.